P. Lefèbvre

A. Scheen, P. Lefèbvre, C. Desaive, 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies.

G. Paolisso, N. Paquot, A. Scheen, 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Stimulation of insulin secretion after prostaglandin PGE 1 in the anesthetized dog.

P. Lefèbvre, A. Luyckx, 1973, Biochemical pharmacology.

Effect of ouabain on insulin secretion in the anesthetized dog.

P. Lefèbvre, A. Luyckx, Pierre Lefebvre, 1972, Biochemical pharmacology.

Diabetes as a Paracrinopathy of the Islets of Langerhans

P. Lefèbvre, 2010 .

Glucagon secretion in diabetic patients with idiopathic haemochromatosis

J. Carpentier, P. Passa, P. Lefèbvre, 1977, Diabetologia.

Presence of pancreatic glucagon in the portal plasma of human neonates. Differences in the insulin and glucagon responses to glucose between normal infants and infants from diabetic mothers

P. Lefèbvre, A. Falorni, A. Luyckx, 1972, Diabetologia.

Glucagon Immunoreactivity and Antidiabetic Action of Somatostatin in the Totally Duodeno-Pancreatectomized and Gastrectomized Human

J. Bringer, J. Mirouze, A. Orsetti, 1981, Diabetes.

Gastric-glucagon: physiology and pathology.

P. Lefèbvre, A. Luyckx, 1978, Advances in experimental medicine and biology.

Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach.

P. Lefèbvre, A. Luyckx, 1978, Endocrinology.

Factors controlling gastric-glucagon release.

P. Lefèbvre, A. Luyckx, 1977, The Journal of clinical investigation.

Pattern of twenty-four plasma amino acids in rats before and after muscular exercise.

P. Lefèbvre, B. Robaye, A. Luyckx, 1972, Archives internationales de physiologie et de biochimie.

Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.

U. Gaspard, A. Scheen, P. Lefèbvre, 1990, American journal of obstetrics and gynecology.

Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme.

A. Scheen, P. Lefèbvre, M. Letiexhe, 1999, Diabetes & metabolism.

Pancreatic B-cell response to a test-meal in lean and obese diabetic patients: Relation to metabolic control

J. Meunier, P. Lefèbvre, J. Daubresse, 1980, Acta diabetologia latina.

Muscular exercise and pancreatic function in rats.

G. Federspil, P. Lefèbvre, A. Luyckx, 1972, Israel journal of medical sciences.

Catecholamines and exercise-induced glucagon and fatty acid mobilization in the rat.

P. Lefèbvre, A. Dresse, A. Luyckx, 1975, The American journal of physiology.

How to measure insulin action in vivo.

N. Paquot, A. Scheen, P. Lefèbvre, 1994, Diabetes/metabolism reviews.

Measurement of insulin sensitivity by the minimal model method using a simplified intravenous glucose tolerance test: validity and reproducibility.

N. Paquot, A. Scheen, B. Duysinx, 1994, Diabete & metabolisme.

Lack of deleterious effects of the alpha1-adrenoceptor blocking agent doxazosin on insulin secretion and insulin sensitivity in healthy men

T. Salvatore, A. Scheen, P. Lefèbvre, 1989 .

Assessment of insulin resistance in vivo: application to the study of type 2 diabetes.

A. Scheen, P. Lefèbvre, 1992, Hormone research.

Metformin : mechanisms of action and clinical use

P. Lefèbvre, D. Andreani, 1995 .

Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats

P. Lefèbvre, C. Hallet, J. Damas, 2001, British journal of pharmacology.

Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age

G. Paolisso, M. Varricchio, F. D'onofrio, 1990, Diabetologia.

Pulsatility of Glucagon

G. Paolisso, A. Scheen, P. Lefèbvre, 1996 .

An introduction to glucagon

P. Lefèbvre, 1993 .

Effect of glucose ingestion on energy substrate utilization during prolonged muscular exercise

P. Lefèbvre, F. Pirnay, A. Luyckx, 1977, European Journal of Applied Physiology and Occupational Physiology.

Plasma C-peptide response to arginine in insulin-dependent diabetic subjects

D. Giugliano, P. Lefèbvre, A. Luyckx, 1980, Journal of endocrinological investigation.

Oral antidiabetic agents. A guide to selection.

A. Scheen, P. Lefèbvre, 1998, Drugs.

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Erland Erdmann, John A Dormandy, Bernard Charbonnel, 2005, The Lancet.

Plasma Insulin in Reactive Hypoglycemia

P. Lefèbvre, A. Luyckx, 1971, Diabetes.

Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study.

F. Grigorescu, P. De Meyts, U. Gaspard, 1986, Fertility and sterility.

Lipids and Lipoproteins in Chronic Uraemia. A Study of the Influence of Regular Haemodialysis **

G. Rorive, P. Lefèbvre, J. Daubresse, 1976, European journal of clinical investigation.

Independance of glucagon and insulin handling by the isolated perfused dog kidney

P. Lefèbvre, A. Luyckx, A. Nizet, 1976, Diabetologia.

Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents.

P. Lefèbvre, J. Daubresse, A. Luyckx, 1979, British journal of clinical pharmacology.

Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology.

A. Scheen, P. Lefèbvre, M. Castillo, 1995, Diabete & metabolisme.

Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin

A. Scheen, P. Lefèbvre, J. Daubresse, 1986, Acta diabetologia latina.

Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in Type 1 (insulin-dependent) diabetic patients

J. Guiot, A. Scheen, P. Lefèbvre, 1989, Diabetologia.

Circadian profiles of blood glucose and plasma free insulin during treatment with Semisynthetic and Biosynthetic human insulin, and comparison with conventional monocomponent preparations

E. Verdin, P. Lefèbvre, A. Luyckx, 2004, European Journal of Clinical Pharmacology.

Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics

P. Lefèbvre, A. Luyckx, E. Mendoza, 1981, Diabetologia.

The Renal Handling of Glucagon

P. Lefèbvre, A. Luyckx, 1983 .

Neuroendocrine-immunology: from systemic interactions to the immune tolerance of self neuroendocrine functions.

J. Martial, P. Franchimont, V. Geenen, 1991, Acta clinica Belgica.

Thymic expression of insulin‐related genes in an animal model of autoimmune type 1 diabetes

D. Greiner, V. Geenen, P. Lefèbvre, 2001, Diabetes/metabolism research and reviews.

Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects.

D. Giugliano, A. Ceriello, P. Lefèbvre, 1991, Clinical science.

Insulin Sensitivity, Clearance and Release in Kininogen‐Deficient Rats

P. Lefèbvre, J. Damas, V. Bourdon, 1999, Experimental physiology.

Insulin effects on glucose kinetics in non-insulin-dependent diabetic patients with secondary failure to hypoglycaemic agents: role of different modes and rates of delivery.

G. Paolisso, M. Varricchio, F. D'onofrio, 1992, European Journal of Medicine.

[Guidelines for the treatment of arterial hypertension in diabetic patients].

A. Scheen, P. Lefèbvre, L. Weekers, 2000, Revue medicale de Liege.

Current views on hypoglycemia and glucagon

V. Marks, P. Lefèbvre, D. Andreani, 1980 .

Inhibition by somatostatin of carbamylcholine-induced gastrin and glucagon release from the isolated perfused canine stomach.

P. Lefèbvre, A. Luyckx, A. Brassinne, 1981, Gut.

Naturally Labeled 13C-Glucose: A New Tool to Measure Oxidation Rates of Exogenous Glucose

P. Lefèbvre, 1979, Diabetes.

Remarkable metabolic availability of oral glucose during long-duration exercise in humans.

N. Pallikarakis, P. Lefèbvre, F. Pirnay, 1986, Journal of applied physiology.

Availability of glucose given orally during exercise.

P. Lefèbvre, F. Pirnay, A. Luyckx, 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

Variability of Albumin Excretion in Insulin‐dependent Diabetics

J. Foidart-Willems, P. Lefèbvre, A. Chachati, 1987, Diabetic medicine : a journal of the British Diabetic Association.

Accumulated experience in the physiology of glucagon

P. Lefèbvre, 1987 .

Blood collection while using a continuous glucose analyzer without insertion of an additional venous catheter

A. Scheen, P. Lefèbvre, A. Luyckx, 1983, Diabetologia.

Insulin-stimulated glucose disposal is not increased in anorexia nervosa.

A. Scheen, P. Lefèbvre, A. Luyckx, 1985, The Journal of clinical endocrinology and metabolism.

Influence of elevated plasma free fatty acids on the glucagon response to hypoglycemia in normal and in pregnant women.

P. Lefèbvre, U. Gaspard, A. Luyckx, 1978, Metabolism: clinical and experimental.

Arguments for a Regulation of Pancreatic Glucagon Secretion by Circulating Plasma Free Fatty Acids

P. Lefèbvre, A. Luyckx, 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Ketosis-Prone Atypical Diabetes: Glucagon Is There, Too

P. Lefèbvre, 2012, Diabetes Care.

Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.

G. Paolisso, A. Scheen, P. Lefèbvre, 1987, The American journal of physiology.

Plasma glucagon after kidney exclusion: experiments in somatostatin-infused and in eviscerated dogs.

P. Lefèbvre, A. Luyckx, 1976, Metabolism: clinical and experimental.

Prostaglandins and Glucagon Secretion

P. Lefèbvre, A. Luyckx, 1983 .

FACTORS CONTROLLING GLUCAGON SECRETION

P. Lefèbvre, A. Luyckx, 1978 .

Glucagonoma and its management

A. Scheen, P. Lefèbvre, 1996 .

Effect of osmolality on availability of glucose ingested during prolonged exercise in humans.

A. Scheen, P. Lefèbvre, F. Pirnay, 1989, Journal of applied physiology.

The postprandial state and risk of cardiovascular disease

A. Scheen, A. Scheen, P. Lefèbvre, 1998, Diabetic medicine : a journal of the British Diabetic Association.

Altered Metabolic and Hormonal Responses to Epinephrine and β-Endorphin in Human Obesity

R. Torella, D. Giugliano, F. D'onofrio, 1988 .

Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma.

J. Legros, L. Delacroix, P. Lefèbvre, 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[Effect of benfluorex on the metabolic fate of an oral glucose load in obese subjects with reduced glucose tolerance (author's transl)].

N. Pallikarakis, P. Lefèbvre, F. Pirnay, 1979, Therapie.

Biological Properties of a Transplantable Islet-cell Tumor of the Golden Hamster: III. Electron Microscopic Studies

T. Grillo, P. Lefèbvre, J. Sodoyez, 1968, Diabetes.

Biological Properties of a Transplantable Islet-cell Tumor of the Golden Hamster: II. Insulin Content of the Tumor and Some Metabolic Characteristics of the Tumor-bearing Animals

P. Lefèbvre, J. Sodoyez, A. Luyckx, 1967, Diabetes.

Intact cross-talk between insulin secretion and insulin action after postgastroplasty recovery of ideal body weight in severely obese patients

A. Scheen, P. Lefèbvre, C. Desaive, 2004, International Journal of Obesity.

Effect of L8027, a new potent inhibitor of prostaglandin biosynthesis, on the metabolism and response to glucagon of rat adipose tissue.

P. Lefèbvre, A. Luyckx, 1974, Biochemical pharmacology.

Effect of Dog Jejunum "Glucagon-Like Immunoreactive Material" on Adipose Tissue Metabolism

R. Unger, I. Valverde, P. Lefèbvre, 1969, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Neurotransmitters and Glucagon Release From the Isolated, Perfused Canine Stomach

P. Lefèbvre, A. Luyckx, 1980, Diabetes.

[Stimulation by carbamylcholine of dog gastric-glucagon release (author's transl) (proceedings)].

P. Lefèbvre, A. Luyckx, A. Brassinne, 1979, Annales d'endocrinologie.

Effect of phosphate on the arginine-induced insulin release by the isolated perfused rat pancreas.

P. Lefèbvre, J. Campillo, A. Luyckx, 1980, Advances in experimental medicine and biology.

Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity.

A. Scheen, P. Lefèbvre, M. Castillo, 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Effect of insulin on glucagon enhanced lipolysis in vitro

P. Lefèbvre, A. Luyckx, P. Lefèbvre, 1969, Diabetologia.

Retinopathy, but not neuropathy, is influenced by the level of residual endogenous insulin secretion in type 2 diabetes.

A. Scheen, P. Lefèbvre, M. Castillo, 1995, Diabete & metabolisme.

Control of diabetes: An attempt to formulate policy guidelines in a department of medicine

P. Lefèbvre, A. Luyckx, P. Lefèbvre, 1974, Diabetologia.

Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity.

A. Scheen, J. Gielen, A. Scheen, 1998, Diabetes & metabolism.

[Eye and the diabetes mellitus].

P. Lefèbvre, D. Toussaint, M. Gilson, 1971, Archives d'ophtalmologie et revue generale d'ophtalmologie.

Vagal stimulation and its role in eliciting gastrin but not glucagon release from the isolated perfused dog stomach.

P. Lefèbvre, A. Luyckx, A. Brassinne, 1978, Gut.

CATECHOLAMINES IN A TRANSPLANTABLE ISLET-CELL TUMOR OF THE GOLDEN HAMSTER

P. Lefèbvre, A. Cession-Fossion, 1970 .

Relationship between plasma free fatty acid levels and human placental lactogen secretion in late pregnancy.

P. Lefèbvre, U. Gaspard, A. Luyckx, 1977, The Journal of clinical endocrinology and metabolism.

Extrapancreatic Glucagon and Its Regulation

P. Lefèbvre, A. Luyckx, 1983 .

Glucagon and the Kidney

P. Lefèbvre, A. Luyckx, 1977 .

Glucagon and gastrin release by the isolated perfused dog stomach in response to arginine.

P. Lefèbvre, A. Luyckx, A. Nizet, 1976, Metabolism: clinical and experimental.

Renal handling of endogenous glucagon in the dog: comparison with insulin.

P. Lefèbvre, A. Luyckx, H. Nizet, 1974, Metabolism: clinical and experimental.

The physiological effect of glucagon on fat-mobilisation

P. Lefèbvre, 1966, Diabetologia.

[Diabetes yesterday, today and tomorrow. The action of the International Diabetes Federation].

P. Lefèbvre, 2005, Revue medicale de Liege.

β-Endorphin Infusion Restores Acute Insulin Responses to Glucose in Type-2 Diabetes Mellitus

G. Paolisso, D. Giugliano, F. D'onofrio, 1987 .

Thymic neuroendocrine self peptides and T cell selection.

P. Franchimont, V. Geenen, A. Benhida, 1994, Advances in experimental medicine and biology.

Pharmacological treatment of the obese diabetic patient.

A. Scheen, P. Lefèbvre, 1993, Diabete & metabolisme.

Detection of Early Sympathetic Cardiovascular Neuropathy by Squatting Test in NIDDM

R. Torella, R. Marfella, T. Salvatore, 1994, Diabetes Care.

GLUCAGON-STIMULATED INSULIN RELEASE

P. Lefèbvre, A. Luyckx, 1966 .

Hormonal and metabolic adaptation to protein-supplemented fasting in obese subjects.

A. Scheen, P. Lefèbvre, A. Luyckx, 1982, International journal of obesity.

Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.

G. Paolisso, F. D'onofrio, N. Passariello, 1987, Diabetes.

[Beta cells in Type II diabetes: culprit or victim?].

N. Paquot, A. Scheen, P. Lefèbvre, 1991, Journees annuelles de diabetologie de l'Hotel-Dieu.

Does insulin release kinins in rats?

N. Garbacki, P. Lefèbvre, J. Damas, 2005, European journal of pharmacology.

Glucagon III

J. Holst, G. Paolisso, D. Bataille, 1996, Handbook of Experimental Pharmacology.

Opioid peptides and metabolic regulation

R. Torella, D. Giugliano, F. D'onofrio, 1988, Diabetologia.

Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections.

A J Scheen, A. Scheen, M. Moutschen, 1992, Diabete & metabolisme.

Circadian variability of kinetics in a transplantable islet-cell tumor of the golden hamster

C. Focan, P. Lefèbvre, A. Luyckx, 2004, Journal of Cancer Research and Clinical Oncology.

Pancreatic Hormones

P. De Meyts, P. Lefèbvre, 2020, Hormonal Signaling in Biology and Medicine.

The intrathymic expression of insulin-related genes: implications for pathophysiology and prevention of Type 1 diabetes.

V. Geenen, P. Lefèbvre, 1998, Diabetes/metabolism reviews.

Microalbuminuria: an early marker of renal involvement in diabetes.

J. Kastrup, B. Feldt-Rasmussen, T. Deckert, 1985, Uremia investigation.

Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man.

G. Paolisso, D. Giugliano, F. D'onofrio, 1987, Acta endocrinologica.

Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity

D. Giugliano, A. Ceriello, P. Lefèbvre, 1990, Diabetologia.

Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients.

J. Belaiche, A. Scheen, P. Lefèbvre, 1993, The Journal of clinical endocrinology and metabolism.

Miscellaneous Pharmacologic Effects of Glucagon

P. Lefèbvre, 1983 .

Glucagon and Catecholamines

P. Lefèbvre, A. Luyckx, 1983 .

[Bronchial reactivity in diabetic patients].

A. Scheen, J. Corhay, M. Radermecker, 1997, Revue des maladies respiratoires.

Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study.

V. Rigalleau, S. Hadjadj, M. Marre, 2004, Diabetes care.

Glucagon, from past to present: a century of intensive research and controversies.

A. Scheen, P. Lefèbvre, 2022, The lancet. Diabetes & endocrinology.

How to measure insulin clearance.

A. Scheen, P. Lefèbvre, M. Letiexhe, 1994, Diabetes/metabolism reviews.

Management of Non-Insulin-Dependent Diabetes Mellitus

A. Scheen, P. Lefèbvre, 2012, Drugs.

Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients.

G. Paolisso, M. Varricchio, F. D'onofrio, 1994, The Journal of clinical endocrinology and metabolism.

Glucagon and its Family Revisited

P. Lefèbvre, 1995, Diabetes Care.

Insulin oscillations per se do not affect glucose turnover parameters in normal man.

G. Paolisso, E. Verdin, A. Scheen, 1986, The Journal of clinical endocrinology and metabolism.

Effects of pulsatile delivery of insulin and glucagon in humans.

A J Scheen, G. Paolisso, A. Scheen, 1989, The American journal of physiology.

Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis.

Johannes D Veldhuis, P. Butler, J. Veldhuis, 2006, Diabetes.

Antiobesity pharmacotherapy in the management of Type 2 diabetes

A. Scheen, P. Lefèbvre, 2000, Diabetes/metabolism research and reviews.

Antihyperglycaemic Agents

A. Scheen, P. Lefèbvre, 1995, Drug safety.

Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.

A. Scheen, A. Scheen, F. Luyckx, 2000, Diabetes & metabolism.

Plasma leptin levels, insulin secretion, clearance and action on glucose metabolism in anorexia nervosa

A. Scheen, P. Lefèbvre, M. Letiexhe, 1997, Eating and weight disorders : EWD.

Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.

A. Scheen, P. Lefèbvre, M. Castillo, 1996, Diabetes & metabolism.

Exhaustion of blood glucose response and enhancement of insulin response after repeated glucagon injections in type-2 diabetes: potentiation by progressive hyperglycemia.

G. Paolisso, A. Scheen, P. Lefèbvre, 1996, Annales d'endocrinologie.

The metabolic syndrome revisited

P. Lefèbvre, 2003 .

Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.

D. Giugliano, P. Lefèbvre, A. Luyckx, 1980, Diabete & metabolisme.

The kallikrein‐kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity

N. Garbacki, P. Lefèbvre, J. Damas, 2004, Diabetes/metabolism research and reviews.

Quantitative evaluation of the oxidation of an exogenous glucose load using naturally labeled 13C-glucose.

J. Duchesne, P. Lefèbvre, F. Pirnay, 1976, Metabolism: clinical and experimental.

On the mechanisms of exercise induced glucagon secretion in rats

P. Lefèbvre, A. Luyckx, 1973 .

Pharmacological compounds affecting plasma glucagon levels in rats.

P. Lefèbvre, A. Luyckx, 1976, Biochemical pharmacology.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.

G. Chatellier, S. Hadjadj, M. Marre, 2005, Diabetes.

Pituitary-testicular axis in diabetic men with and without sexual impotence.

J. Meunier, P. Lefèbvre, J. Daubresse, 1978, Diabete & metabolisme.

Severe/extreme obesity: a medical disease requiring a surgical treatment?

A. Scheen, F. Luyckx, P. Lefèbvre, 1999, Acta clinica Belgica.

Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control.

A. Albert, P. Lefèbvre, A. Albert, 2001, Diabetes care.

A role for beta-endorphin in the pathogenesis of human obesity?

D. Giugliano, P. Lefèbvre, 1991, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Persistence of altered metabolic responses to beta-endorphin after normalization of body weight in human obesity.

R. Torella, D. Giugliano, F. D'onofrio, 1991, Acta endocrinologica.

Glucose Naturally Labeled with Carbon-13: Use for Metabolic Studies in Man

P. Lefèbvre, A. Luyckx, G. López-Habib, 1973, Science.

[Proactive study: secondary cardiovascular prevention with pioglitazione in type 2 diabetic patients].

A. Scheen, P. Lefèbvre, 2005, Revue medicale de Liege.

Influence of the bicarbonate pool and on the occurrence of 13CO2 in exhaled air

N. Pallikarakis, P. Lefèbvre, N. Sphiris, 2004, European Journal of Applied Physiology and Occupational Physiology.

Metabolic adaptations in post-exercise recovery.

N. Pallikarakis, P. Lefèbvre, F. Pirnay, 1982, Clinical physiology.

Type 2 diabetes mellitus: integration in view, at last!

P. Lefèbvre, 2008, Diabetes & metabolism.

Glucose oxidation in relation to the size of the oral glucose loading dose.

N. Pallikarakis, P. Lefèbvre, F. Pirnay, 1981, Metabolism: clinical and experimental.

Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease

U. Gaspard, P. Lefèbvre, 1991 .

The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man.

P. Franchimont, N. Paquot, A. Scheen, 1988, Diabete & metabolisme.

Influence of the A→G (-3826) uncoupling protein-1 gene (UCP1) variant on the dynamics of body weight before and after gastroplasty in morbidly obese subjects

J. Gielen, A. Scheen, F. Luyckx, 1998, International Journal of Obesity.

Diabetes and Tuberculosis - Old Associates Posing a Renewed Public Health Challenge

A. Harries, I. Bygbjerg, K. Lönnroth, 2009 .

Current Issues International Health and Diabetes Diabetes and Tuberculosis – Old Associates Posing a Renewed Public Health Challenge

I. Bygbjerg, K. Lönnroth, A. Kapur, 2009 .

The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level.

A. Scheen, P. Lefèbvre, M. Castillo, 1996, The Journal of clinical endocrinology and metabolism.

Pancreatic transplantation: Why, when and who?

P. Lefèbvre, Dr. P. J. Lefèbvre, 1992, Diabetologia.

Obesity: causes and new treatments.

A. Scheen, P. Lefèbvre, 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

From plant physiology to human metabolic investigations

P. Lefèbvre, 1985, Diabetologia.

Exogenous Glucose Oxidation During Exercise in Relation to the Power Output

J. Gautier, A. Scheen, P. Lefèbvre, 1995, International journal of sports medicine.

Effect of physical training on utilization of a glucose load given orally during exercise.

P. Lefèbvre, F. Pirnay, A. Luyckx, 1984, The American journal of physiology.

Effect of physical training on the oxidation of an oral glucose load at rest: a naturally labeled 13C-glucose study.

P. Lefèbvre, F. Pirnay, A. Luyckx, 1983, Diabete & metabolisme.

[Role of glucagon in diabetes].

P. Lefèbvre, A. Luyckx, 1981, La Revue du praticien.

Thymic cryptocrine signaling and the immune recognition of self neuroendocrine functions

J. Martial, P. Franchimont, V. Geenen, 1991 .

Risk of Developiment and progression of retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control

A. Albert, P. Lefèbvre, G. Krzentowski, 2000 .

Adipose Tissue Lipolysis in Golden Hamsters with Chronic Hypoglycemia and Hyperinsulinemia Due to a Transplantable Islet Cell Tumor*

P. Lefèbvre, J. Sodoyez, A. Luyckx, 1970, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Inhibition of Glucagon Secretion in the Human Newborn by Simultaneous Administration of Glucose and Insulin

P. Lefèbvre, A. Falorni, A. Luyckx, 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Parallel reversibility of biological markers of the metabolic syndrome and liver steatosis after gastroplasty-induced weight loss in severe obesity.

A. Scheen, F. Luyckx, P. Lefèbvre, 1999, The Journal of clinical endocrinology and metabolism.

Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women.

A. Scheen, P. Lefèbvre, C. Desaive, 1995, The Journal of clinical endocrinology and metabolism.

Effect of Somatostatin in the Syrian Hamster Bearing a Transplantable Islet-Cell Tumor*

P. Lefèbvre, A. Luyckx **, 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[A transplantable insuloma of the Syrian hamster Mesocricetus auratus auratus. Review of its properties and of its effects on the host].

P. Lefèbvre, J. Sodoyez, F. Sodoyez-Goffaux, 1968, Acta diabetologica latina.

Glucagon secretion by the transplantable islet-cell tumor of the Syrian hamster.

P. Lefèbvre, A. Luyckx, 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control

A. Scheen, P. Lefèbvre, A. Luyckx, 1983, Diabetologia.

Reduction of the acute bioavailability of metformin by the α‐glucosidase inhibitor acarbose in normal man

T. Salvatore, A. Scheen, P. Lefèbvre, 1994, European journal of clinical investigation.

Plasma glucagon levels in normal women during pregnancy

P. Lefèbvre, U. Gaspard, A. Luyckx, 1975, Diabetologia.

Letter: Potentiation of hypoglycemic effect of sulfonylureas by clofibrate.

P. Lefèbvre, J. Daubresse, A. Luyckx, 1976, New England Journal of Medicine.

The global challenge of diabetes

T. Lancet, P. Lefèbvre, Pierre Lefèbvre, 2008, The Lancet.

Effect of somatostatin on metabolic and hormonal changes induced by nicotinic acid in insulin-dependent diabetics

P. Lefèbvre, A. Luyckx, 1976, Diabetologia.

Effects of metformin in obese patients with impaired glucose tolerance.

A. Scheen, P. Lefèbvre, M. Letiexhe, 1995, Diabetes/metabolism reviews.

[Reactive hypoglycaemia, a mysterious, insidious but non dangerous critical phenomenon].

A. Scheen, P. Lefèbvre, 2004, Revue medicale de Liege.

The intriguing diversity of the glucagon gene products

P. Lefèbvre, 2002, Current diabetes reports.

Possible role of endogenous prostaglandins in glucagon secretion by isolated guinea-pig islets

P. Lefèbvre, A. Luyckx, 1978, Diabetologia.

Oxidation of an exogenous glucose load using naturally labelled 13C-glucose

P. Lefèbvre, F. Pirnay, A. Luyckx, 1978, Diabetologia.

Effect of glucose on plasma glucagon and free fatty acids during prolonged exercise

P. Lefèbvre, F. Pirnay, A. Luyckx, 1978, European Journal of Applied Physiology and Occupational Physiology.

[Magnesium and glucose metabolism].

G. Paolisso, A. Scheen, P. Lefèbvre, 1994, Therapie.

Use of 13C substrates for metabolic studies in exercise: methodological considerations.

N. Pallikarakis, J. Riou, J. Gautier, 1991, Journal of applied physiology.

Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide.

M. Lecomte, P. Lefèbvre, A. Luyckx, 1977, Diabete & metabolisme.

Endocrine Mechanisms of Exercise-Induced Fatty Acids Mobilization in Rats

G. Federspil, P. Lefèbvre, A. Luyckx, 1975 .

Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon.

M. Lecomte, P. Lefèbvre, A. Luyckx, 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Effect of indomethacin on the metabolic and hormonal response to a standardized breakfast in normal subjects

F. Jaminet, A. Scheen, P. Lefèbvre, 1981, Acta diabetologia latina.

[Non-insulin-dependent diabetes: an expanding disease. Importance of a multidisciplinary approach].

P. Lefèbvre, 2003, Bulletin de l'Academie nationale de medecine.